MAGEL2
protein-codingMAGE family member L2, the group of MAGE family
Gene summary
Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
- NDNL1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~4.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014243
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014243
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014243
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0014243
Submitter: ClinGen
*MAGEL2* is a single exon gene located on the maternally imprinted (paternally expressed) locus on chromosome 15q11–q13. *MAGEL2* was first reported in relation to autosomal dominant Schaaf-Yang syndrome in 2013 (Schaaf et al., PMID: 24076603). Schaaf-Yang syndrome is a rare neurodevelopmental disorder that shares multiple clinical features with Prader-Willi syndrome. It usually manifests at birth with muscular hypotonia in all and distal joint contractures in a majority of affected individuals. Gastrointestinal/feeding problems are particularly pronounced in infancy and childhood, but can transition to hyperphagia and obesity in adulthood. All affected individuals show developmental delay, resulting in intellectual disability of variable degree. Other findings may include short stature, seizures, eye anomalies, and hypogonadism. Some patients were originally referred as Chitayat-Hall syndrome but as the molecular mechanism is the same (null variant on the paternal allele), these disease entities were lumped together. Thirteen variants (nonsense and frameshift) that have been reported in 16 probands in five publications (PMIDs: 24076603, 26365340, 27195816, 28281571, 33076953) are included in this curation. Many more patients are reported in the literature, especially with the recurrent variants c.1996dupC and c.1996delC (reviewed in PMID: 30302899), but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be truncating variation on the paternal allele. This gene-disease association is also supported by experimental evidence, including two mouse models (PMIDs: 17893678, 20876615). In summary, there is definitive evidence supporting the relationship between *MAGEL2* and autosomal dominant Schaaf-Yang syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on June 1, 2021 (SOP Version 8). As of August 2026, this record underwent administrative updates to update scoring to be consistent with SOP Version 12. No new evidence was added, and the classification remains the same.
Inheritance Pattern: AD
Disease ID:MONDO:0014243
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Genitourinary; Musculoskeletal; Neurologic
Intervention: Endocrine
Rationale: The condition has been described as including neonatal hyperinsulinemia hypoglycemia, and awareness may allow prompt management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MAGEL2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_019066.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 84 | 208 | 6 | 298 | ||
| missense | 2 | 1 | 876 | 125 | 7 | 1011 |
| nonsense | 20 | 27 | 5 | 52 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 26 | 41 | 9 | 76 | ||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 48 | 70 | 975 | 333 | 13 | 1439 |
Highest pathogenic variant AF is 0.00001549108
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_061939.3 | 1 | MANE Select | |
| Ensembl | ENSP00000497810.1 | 1 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Circadian rythm related genes
- Prader-Willi and Angelman Syndrome
Biological Process
- Arp2/3 complex-mediated actin nucleation
- retrograde transport, endosome to Golgi
- regulation of circadian rhythm
- negative regulation of transcription, DNA-templated
- rhythmic process
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
Cellular Component
- nucleus
- endosome
- early endosome
- cytosol
- retromer complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000532292
- Coding exons
- 1
- Length
- 2485
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.563 | 399 | 369 | 1.08 | 0.0000209 | 4145 |
| Missense (PolyPhen) | 76 | 73.131 | 1.0392 | 861 | ||
| Synonymous | -1.72 | 185 | 158 | 1.17 | 0.00000941 | 1352 |
| Loss of Function | 3.75 | 2 | 20.2 | 0.0992 | 0.00000112 | 209 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probably enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases, possibly through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. Acts as a regulator of retrograde transport via its interaction with VPS35. Recruited to retromer-containing endosomes and promotes the formation of 'Lys- 63'-linked polyubiquitin chains at 'Lys-220' of WASHC1 together with TRIM27, leading to promote endosomal F-actin assembly (PubMed:23452853). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Significantly promotes the cytoplasmic accumulation of CLOCK (By similarity). {ECO:0000250|UniProtKB:Q9QZ04, ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:23452853}.;
Essentials
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |